10 Einträge von 551 mit permission japan
www.cslbehring.ch
Datum der Indexierung 13.09.2023 07:44:10
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | website services | this these | information without | such learn | that products | your more | terms from | content with | other visitors |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | website services | this these | information without | such learn | that products | your more | terms from | content with | other visitors |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
www.cslbehring.ch
Datum der Indexierung 02.10.2023 14:46:05
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma approval | with learn | approved award | patients switzerland | treatment immunglobulin | production market | factor company | bern more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma approval | with learn | approved award | patients switzerland | treatment immunglobulin | production market | factor company | bern more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung 02.10.2023 14:48:22
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such learn | that with | terms products | your more | visitors from | other content |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such learn | that with | terms products | your more | visitors from | other content |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
www.cslbehring.ch
Datum der Indexierung 05.10.2023 09:47:16
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma approval | with learn | approved award | patients switzerland | treatment immunglobulin | production market | factor company | bern more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma approval | with learn | approved award | patients switzerland | treatment immunglobulin | production market | factor company | bern more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung 05.10.2023 09:31:31
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such learn | that with | terms products | your more | visitors from | other content |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such learn | that with | terms products | your more | visitors from | other content |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
www.cslbehring.ch
Datum der Indexierung 26.10.2023 20:55:57
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma switzerland | with approval | approved learn | patients award | treatment immunglobulin | production market | factor more | bern company |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first blood | plasma switzerland | with approval | approved learn | patients award | treatment immunglobulin | production market | factor more | bern company |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung 26.10.2023 20:58:14
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | that learn | such with | terms products | your more | visitors from | content other |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | that learn | such with | terms products | your more | visitors from | content other |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:21:44
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring deficiency | first switzerland | plasma plant | with approval | approved award | treatment learn | patients immunglobulin | production bern | factor market | more company |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring deficiency | first switzerland | plasma plant | with approval | approved award | treatment learn | patients immunglobulin | production bern | factor market | more company |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung 08.01.2024 08:24:00
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such products | that learn | terms with | your from | content more | other visitors |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Terms of Use PLEASE READ THE FOLLOWING TERMS OF USE CAREFULLY. THEY APPLY TO ALL WEBSITE VISITORS. About this website
Kombination Keywords behring policy | this services | website these | information without | such products | that learn | terms with | your from | content more | other visitors |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission of CSL Behring. This excludes the downloading of a single copy of this website by visitors to our website for purely informational, non-commercial purposes. CSL Behring reserves the right, to restrict or terminate any visitor’s use of or a Japan Korea Singapore Taiwan Middle East Saudi Arabia United Arab Emirates (MEA) Europe Austria Belgium and Luxembourg Czech Republic Denmark Finland France Germany Greece Hungary Iceland Italy Netherlands Norway Poland Slovakia S
Text Inhalt Text aus URL
Log Metriken 32788
www.cslbehring.ch
Datum der Indexierung 15.01.2024 02:34:08
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring drug | first deficiency | plasma switzerland | with plant | approved award | patients approval | treatment immunglobulin | factor bern | production market | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring drug | first deficiency | plasma switzerland | with plant | approved award | patients approval | treatment immunglobulin | factor bern | production market | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
permission to manufacture products using blood plasma The Swiss government empowers ZLB to sell medicine made of blood plasma via the blood donation service of the Swiss Red Cross. 1949 Foundation of ZLB Under the auspices of the Swiss Red Cross (SRK Japan’s first fibrin adhesive Beriplast® P is the first fibrin adhesive to arrive on the Japanese market. 1986 Approval for Humate-P® in the U.S. Humate-P®, the plasma protein concentrate with coagulation factor VIII/von Willebran
Text Inhalt Text aus URL
Log Metriken 32759